☰

Marianna Halasi, Ph.D. - Publications

Affiliations: 
2012 Biochemistry and Molecular Genetics University of Illinois at Chicago, Chicago, IL, United States 
Area:
Molecular Biology, Biochemistry
Tree Info Similar researchers PubMed Report error

28 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Chesnokov MS, Borhani S, Halasi M, Arbieva Z, Khan I, Gartel AL. FOXM1-AKT Positive Regulation Loop Provides Venetoclax Resistance in AML. Frontiers in Oncology. 11: 696532. PMID 34381718 DOI: 10.3389/fonc.2021.696532  0.676
2021 Chesnokov MS, Halasi M, Borhani S, Arbieva Z, Shah BN, Oerlemans R, Khan I, Camacho CJ, Gartel AL. Novel FOXM1 inhibitor identified via gene network analysis induces autophagic FOXM1 degradation to overcome chemoresistance of human cancer cells. Cell Death & Disease. 12: 704. PMID 34262016 DOI: 10.1038/s41419-021-03978-0  0.706
2018 Khan I, Halasi M, Patel A, Schultz R, Kalakota N, Chen YH, Aardsma N, Liu L, Crispino JD, Mahmud N, Frankfurt O, Gartel AL. FOXM1 contributes to treatment failure in acute myeloid leukemia. Jci Insight. 3. PMID 30089730 DOI: 10.1172/Jci.Insight.121583  0.663
2018 Halasi M, Hitchinson B, Shah BN, Váraljai R, Khan I, Benevolenskaya EV, Gaponenko V, Arbiser JL, Gartel AL. Honokiol is a FOXM1 antagonist. Cell Death & Disease. 9: 84. PMID 29367668 DOI: 10.1038/S41419-017-0156-7  0.699
2017 Khan I, Halasi M, Gartel AL. Abstract 28: The novel role of FOXM1 in AML Clinical Cancer Research. 23: 28-28. DOI: 10.1158/1557-3265.Hemmal17-28  0.554
2016 Khan I, Halasi M, Zia MF, Gann P, Gaitonde S, Mahmud N, Gartel AL. Nuclear FOXM1 drives chemoresistance in AML. Leukemia. PMID 27694928 DOI: 10.1038/Leu.2016.270  0.567
2016 Halasi M, Váraljai R, Benevolenskaya E, Gartel AL. A Novel Function of Molecular Chaperone HSP70: SUPPRESSION OF ONCOGENIC FOXM1 AFTER PROTEOTOXIC STRESS. The Journal of Biological Chemistry. 291: 142-8. PMID 26559972 DOI: 10.1074/Jbc.M115.678227  0.693
2016 Khan I, Gartel A, Halasi M. Inhibition of FOXM1 By Ixazomib Confers Chemosensitivity in NPM1-Wild Type Acute Myeloid Leukemia Blood. 128: 1577-1577. DOI: 10.1182/Blood.V128.22.1577.1577  0.711
2015 Khan I, Zia M, Halasi M, Gann P, Gaitonde S, Gartel A. FOXM1 Binds Nucleophosmin in AML and Confers Resistance to Chemotherapy Blood. 126: 2467-2467. DOI: 10.1182/Blood.V126.23.2467.2467  0.683
2014 Halasi M, Pandit B, Gartel AL. Proteasome inhibitors suppress the protein expression of mutant p53. Cell Cycle (Georgetown, Tex.). 13: 3202-6. PMID 25485499 DOI: 10.4161/15384101.2014.950132  0.664
2014 Halasi M, Gartel AL. Abstract 3523: Targeting FOXM1 in pancreatic cancer Cancer Research. 74: 3523-3523. DOI: 10.1158/1538-7445.Am2014-3523  0.588
2014 Halasi M, Gartel AL. Sa1376 FOXM1 As a Potential Target in Pancreatic Cancer Gastroenterology. 146: S-277. DOI: 10.1016/S0016-5085(14)60978-1  0.647
2013 Halasi M, Wang M, Chavan TS, Gaponenko V, Hay N, Gartel AL. ROS inhibitor N-acetyl-L-cysteine antagonizes the activity of proteasome inhibitors. The Biochemical Journal. 454: 201-8. PMID 23772801 DOI: 10.1042/Bj20130282  0.656
2013 Halasi M, Pandit B, Wang M, Nogueira V, Hay N, Gartel AL. Combination of oxidative stress and FOXM1 inhibitors induces apoptosis in cancer cells and inhibits xenograft tumor growth. The American Journal of Pathology. 183: 257-65. PMID 23665201 DOI: 10.1016/J.Ajpath.2013.03.012  0.729
2013 Halasi M, Gartel AL. FOX(M1) news--it is cancer. Molecular Cancer Therapeutics. 12: 245-54. PMID 23443798 DOI: 10.1158/1535-7163.Mct-12-0712  0.72
2013 Halasi M, Gartel AL. Targeting FOXM1 in cancer. Biochemical Pharmacology. 85: 644-52. PMID 23103567 DOI: 10.1016/J.Bcp.2012.10.013  0.717
2012 Wang M, Halasi M, Kabirov K, Banerjee A, Landolfi J, Lyubimov AV, Gartel AL. Combination treatment with bortezomib and thiostrepton is effective against tumor formation in mouse models of DEN/PB-induced liver carcinogenesis. Cell Cycle (Georgetown, Tex.). 11: 3370-2. PMID 22894930 DOI: 10.4161/Cc.21290  0.67
2012 Halasi M, Gartel AL. Suppression of FOXM1 sensitizes human cancer cells to cell death induced by DNA-damage. Plos One. 7: e31761. PMID 22393369 DOI: 10.1371/Journal.Pone.0031761  0.694
2011 Bhat UG, Jagadeeswaran R, Halasi M, Gartel AL. Nucleophosmin interacts with FOXM1 and modulates the level and localization of FOXM1 in human cancer cells. The Journal of Biological Chemistry. 286: 41425-33. PMID 21979956 DOI: 10.1074/Jbc.M111.270843  0.709
2011 Pandit B, Wang M, Halasi M, Gartel AL. Abstract 2626: Thiazole antibiotic/proteasome inhibitor thiostrepton against cancer Cancer Research. 71: 2626-2626. DOI: 10.1158/1538-7445.Am2011-2626  0.528
2010 Halasi M, Zhao H, Dahari H, Bhat UG, Gonzalez EB, Lyubimo AV, Tonetti DA, Gartel AL. Thiazole antibiotics against breast cancer. Cell Cycle (Georgetown, Tex.). 9: 1214-7. PMID 20410687 DOI: 10.4161/Cc.9.6.10955  0.704
2009 Pandit B, Halasi M, Gartel AL. p53 negatively regulates expression of FoxM1. Cell Cycle (Georgetown, Tex.). 8: 3425-7. PMID 19806025 DOI: 10.4161/Cc.8.20.9628  0.689
2009 Bhat UG, Halasi M, Gartel AL. FoxM1 is a general target for proteasome inhibitors. Plos One. 4: e6593. PMID 19672316 DOI: 10.1371/Journal.Pone.0006593  0.734
2009 Halasi M, Schraufnagel DP, Gartel AL. Wild-type p53 protects normal cells against apoptosis induced by thiostrepton. Cell Cycle (Georgetown, Tex.). 8: 2850-1. PMID 19652535 DOI: 10.4161/Cc.8.17.9414  0.703
2009 Bhat UG, Halasi M, Gartel AL. Thiazole antibiotics target FoxM1 and induce apoptosis in human cancer cells. Plos One. 4: e5592. PMID 19440351 DOI: 10.1371/Journal.Pone.0005592  0.75
2009 Halasi M, Gartel AL. A novel mode of FoxM1 regulation: positive auto-regulatory loop. Cell Cycle (Georgetown, Tex.). 8: 1966-7. PMID 19411834 DOI: 10.4161/Cc.8.12.8708  0.674
2008 Radhakrishnan SK, Halasi M, Bhat UG, Kurmasheva RT, Houghton PJ, Gartel AL. Proapoptotic compound ARC targets Akt and N-myc in neuroblastoma cells. Oncogene. 27: 694-9. PMID 17724478 DOI: 10.1038/Sj.Onc.1210692  0.691
2008 Radhakrishnan SK, Bhat UG, Halasi M, Gartel AL. P-TEFb inhibitors interfere with activation of p53 by DNA-damaging agents. Oncogene. 27: 1306-9. PMID 17724473 DOI: 10.1038/Sj.Onc.1210737  0.657
Show low-probability matches.